Back to search

Sweden· SE-19971017000056

Iomeron 150 mg I/ml Injektionsvätska, lösning

A medicinal product containing iomeprol, registered in Sweden by Bracco Imaging SpA.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedIomeron 150 mg I/ml Injektionsvätska,…ATC—REGISTER NO.SE-19971017000056PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Iomeprol
Manufacturer
Bracco Imaging SpA
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    19971017000056

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Iomeprol in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All iomeprol products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Austria · Iomeron
  • Belgium · Iomeron
  • Bulgaria · Iomeron
  • Czechia · Iomeron
  • Germany · Imeron
  • Denmark · Iomeron
  • Spain · Iomeron
  • Finland · Iomeron
  • France · Iomeron
  • United Kingdom (Northern Ireland) · Iomeron
  • Greece · Iomeron
  • Croatia · Iomeron
  • Hungary · Iomeron
  • Ireland · Iomeron
  • Italy · Iomeron
  • Luxembourg · Iomeron
  • Netherlands · Iomeron
  • Norway · Iomeron
  • Poland · Iomeron
  • Portugal · Iomeron
  • Romania · Iomeron
  • Slovenia · Iomeron
  • Slovakia · Iomeron 150, Iomeron 200

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/92fcbcec-c1cc-4d1d-9028-59b482da7d6f
GET /v1/drugs/92fcbcec-c1cc-4d1d-9028-59b482da7d6f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "SmPC",
    "Dispensbeslut",
    "sRMP",
    "PL"
  ],
  "se_npl_id": "19971017000056",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19971017000056",
  "product_doc_link": "https://docetp.mpa.se/LMF/Iomeron%20solution%20for%20injection%20SmPC_09001bee807a4a78.pdf"
}

See everything about iomeprol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.